Oppenheimer Fall Summit focused on Spec Pharma & Rare Disease


Both days will feature 1on1 meetings with a select group of companies focused on specialty pharma and orphan and rare disease. Investors will have the opportunity to meet with management teams to discuss in detail key therapeutic programs in development and recent corporate updates.


We look forward to your participation.


To access information for the Fall Summit, please enter your password. Your password can be found in the email invitation that was sent to you.


Conferences are only open to established institutional clients of Oppenheimer & Co. Inc. For more information, please contact your Oppenheimer & Co. Inc. institutional sales representative.



In this article: